R

Rocket Pharmaceuticals
D

RCKT

14.100
USD
1.31
(10.24%)
Market Closed
Volume
49,992
EPS
-2
Div Yield
-
P/E
-5
Market Cap
1,285,314,899
OverviewSignalsIdeasNews
Related Instruments
    A
    ASTC
    -0.04000
    (-0.57%)
    6.99000 USD
    BA
    BA
    2.055
    (1.49%)
    149.28 USD
    GD
    GD
    -4.47
    (-1.53%)
    287.97 USD
    K
    KTOS
    -0.875
    (-3.46%)
    24.415 USD
    LMT
    LMT
    -4.08
    (-0.76%)
    542.12 USD
    M
    MAXR
    0
    (0%)
    0.000000 USD
    NOC
    NOC
    -6.47
    (-1.29%)
    493.99 USD
    RTX
    RTX
    -0.380
    (-0.32%)
    120.75 USD
    S
    SPCE
    0.19500
    (2.97%)
    6.76000 USD
    U
    U
    -1.510
    (-8.01%)
    17.330 USD
    More
News

Title: Rocket Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.